SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

WEEDCOIN.X is trending as community members highlight its association with cannabis culture and speculate on potential benefits from shifts in cannabis legislation. The community emphasizes WEEDCOIN.X as more than just a token, but rather a movement that encompasses culture, freedom, and community growth. Some users are comparing it favorably to traditional cannabis stocks.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending following a significant drop, reportedly due to investor reactions to mixed trial data despite positive aspects. The community is debating whether this is an overreaction, a buying opportunity given the company's cash position, or a sign of deeper issues. Some are speculating about a potential acquisition or short squeeze.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a sharp intraday drop sparked by a former FDA employee's LinkedIn post questioning the efficacy and safety of their drug Lupkynis, which has ignited community outrage and accusations of market manipulation.  Shareholders are calling for legal action against the individual, demanding a response from Aurinia's leadership, and speculating about potential motives behind the post, including short-selling or personal vendettas. Despite the controversy, some investors view the dip as a buying opportunity, citing the drug's established approval and potential for a buyout.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels is trending due to a proposed $550 million convertible senior notes offering, leading to concerns about stock dilution among investors. While long-term holders express confidence in the company's investments in the uranium sector amid expected price increases, others worry about short-term price volatility and await news to drive further stock appreciation.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as investors anticipate potential benefits from cannabis rescheduling following supportive comments and actions from key political figures. Community discussions revolve around the timing and magnitude of potential policy changes, with some highlighting the sector's suppressed state and potential for significant gains. Traders are closely watching for further catalysts and the impact of regulatory developments on the cannabis industry.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending amid discussions around its stock performance and potential value, with some investors seeing the dip as a buying opportunity while others express concern about its valuation and recent performance. Community members are debating the company's growth prospects and comparing it to competitors like Chipotle, while also discussing new menu items and marketing strategies. Recent news about the COO leaving and broader concerns about the consumer environment have added to the conversation.

AKIRA LABS

AKIRA.X is gaining attention alongside other tokens like WAGMI.X and SOL.X, potentially signaling interest in a new meme coin cycle. The community is actively adding it to watchlists and highlighting it as a potentially strong project.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding ($BQ) is trending due to discussions around its low float and potential for a significant price squeeze, similar to other recent runners. The community is actively debating potential offering and short squeeze. Traders are also weighing bullish versus bearish scenarios, with some anticipating a multi-day run while others foresee a pullback.

Eupraxia Pharmaceuticals, Inc. operates as a drug delivery technology company in Canada. It delivers drugs into body compartments, such as the joint without any of the common issues with body compartment injections, such as systemic exposure. The firm focuses on arthritis, diabetic macular edema, and chronic pain programs. The company was founded by James A. Helliwell, John Salvatore Montalbano and Amanda Malone on May 12, 2011 and is headquartered in Victoria, Canada.

Eupraxia Pharmaceuticals Inc

EPRX is trending due to positive data from its RESOLVE trial for Eosinophilic Esophagitis (EoE), with the community highlighting the potential for EP-104GI to improve the standard of care. Discussions also focus on a recent public offering and analyst ratings, with some traders noting the stock's low float and potential for significant movement. The company's DiffuSphere technology and its broader applications are also being mentioned.

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

4D Molecular Therapeutics Inc

FDMT is trending as traders discuss its pipeline and potential catalysts, particularly around 4D-150 for wet AMD and DME. The community is actively debating the company's prospects ahead of upcoming data releases and presentations, with some anticipating partnership news. Discussions also include short squeeze potential given the company's financial position and institutional ownership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is It Worth Investing in Nextracker (NXT) Based on Wall Street's Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in Nextracker (NXT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Clean Energy ETFs Slide Post Trump's Remark at UN: A Bumpy Road Ahead?

Trump's sharp criticism of green energy rattles investors, sending U.S. clean energy ETFs like ICLN, QCLN, ACES, TAN and PBW lower. 

Investors Heavily Search Nextracker Inc. (NXT): Here is What You Need to Know

Nextracker (NXT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Nextracker (NXT) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Nextracker (NXT) closed at $73.14, marking a +2.51% move from the previous day.

Nextracker (NXT) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw Nextracker (NXT) settling at $67.64, representing a +1.41% change from its previous close.

Based on the average brokerage recommendation (ABR), Nextracker (NXT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Here is What to Know Beyond Why Nextracker Inc. (NXT) is a Trending Stock

Nextracker (NXT) Stock Falls Amid Market Uptick: What Investors Need to Know

The latest trading day saw Nextracker (NXT) settling at $64.33, representing a -7.78% change from its previous close.

ENPH Starts US Pre-Orders for IQ9 Commercial Microinverters With GaN

Enphase Energy begins U.S. pre-orders for its IQ9N-3P Commercial Microinverter to boost efficiency and cut installation costs in commercial solar energy.

Zacks Investment Ideas feature highlights: Invesco Solar ETF, Shoals Technology Group, Array Technologies and Nextracker

As AI drives surging power demand, solar emerges as a cost-effective winner, lifting Shoals, Array, Nextracker, and the Invesco Solar ETF.

Nextracker, Inc. engages in the provision of integrated solar tracker and software solutions used in utility-scale and ground-mounted distributed generation solar projects. Its products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. The company was founded by Daniel S. Shugar, Alexander Au, Nicholas Miller, Michael Mehavich, Marco Garcia, and Tyroan Hardy in 2013 and is headquartered in Fremont, CA.

Nextracker Inc - Ordinary Shares - Class A

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '25	$1.01	--	--	N/A
Q1 '25	$1.03	$1.16	12.65%	BEAT
Q4 '24	$0.96	$1.29	33.99%	BEAT
Q3 '24	$0.58	$1.03	77.65%	BEAT
Q2 '24	$0.60	$0.97	60.49%	BEAT

NXT
Nextracker Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '25

Historical Earnings

Latest NXT News

NXT Nextracker Inc - Ordinary Shares - Class A